Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesOther Gross PP&E AdjustmentsShares Issued
Ratios

Amicus Therapeutics (FOLD) Depreciation Expense (2016 - 2019)

Historic Depreciation Expense for Amicus Therapeutics (FOLD) over the last 6 years, with Q1 2019 value amounting to $991000.0.

  • Amicus Therapeutics' Depreciation Expense rose 227.04% to $991000.0 in Q1 2019 from the same period last year, while for Mar 2019 it was $4.2 million, marking a year-over-year increase of 1270.69%. This contributed to the annual value of $5.0 million for FY2024, which is 416.67% up from last year.
  • As of Q1 2019, Amicus Therapeutics' Depreciation Expense stood at $991000.0, which was up 227.04% from $1.2 million recorded in Q4 2018.
  • Over the past 5 years, Amicus Therapeutics' Depreciation Expense peaked at $1.2 million during Q4 2018, and registered a low of $353000.0 during Q2 2015.
  • Moreover, its 5-year median value for Depreciation Expense was $873500.0 (2016), whereas its average is $830562.5.
  • Its Depreciation Expense has fluctuated over the past 5 years, first crashed by 1085.86% in 2015, then surged by 12683.54% in 2016.
  • Amicus Therapeutics' Depreciation Expense (Quarter) stood at $395000.0 in 2015, then surged by 129.37% to $906000.0 in 2016, then increased by 22.96% to $1.1 million in 2017, then rose by 6.37% to $1.2 million in 2018, then dropped by 16.37% to $991000.0 in 2019.
  • Its Depreciation Expense stands at $991000.0 for Q1 2019, versus $1.2 million for Q4 2018 and $1.1 million for Q3 2018.